Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 10/2014

01-10-2014 | Letter to the Editor

Dramatic and prompt efficacy of Helicobacter pylori eradication in the treatment of severe refractory iron deficiency anemia in adults

Authors: Jun Yamanouchi, Taichi Azuma, Yoshihiro Yakushijin, Takaaki Hato, Masaki Yasukawa

Published in: Annals of Hematology | Issue 10/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hershko C, Camaschella C (2014) How I treat unexplained refractory iron deficiency anemia. Blood 123:326–333PubMedCrossRef
2.
Muhsen K, Cohen D (2008) Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 13:323–340PubMedCrossRef
3.
Cardenas VM, Mulla ZD, Ortiz M, Graham DY (2006) Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 163:127–134PubMedCrossRef
4.
Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD (2006) Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics 117:e396–404PubMedCrossRef
5.
Muhsen K, Barak M, Henig C, Alpert G, Ornoy A, Cohen D (2010) Is the association between Helicobacter pylori infection and anemia age dependent? Helicobacter 15:467–472PubMedCrossRef
6.
Azab SF, Esh AM (2013) Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case–control study. Ann Hematol 92:1477–1483PubMedCrossRef
7.
Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G (2003) Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 52:496–501PubMedCentralPubMedCrossRef
8.
Lee JH, Choe YH, Choi YO (2009) The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia. Helicobacter 14:36–39PubMedCrossRef
9.
Tan S, Noto JM, Romero-Gallo J, Peek RM Jr, Amieva MR (2011) Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 7:e1002050PubMedCentralPubMedCrossRef
10.
Noto JM, Gaddy JA, Lee JY et al (2013) Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 123:479–492PubMedCentralPubMedCrossRef
Metadata
Title
Dramatic and prompt efficacy of Helicobacter pylori eradication in the treatment of severe refractory iron deficiency anemia in adults
Authors
Jun Yamanouchi
Taichi Azuma
Yoshihiro Yakushijin
Takaaki Hato
Masaki Yasukawa
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2052-x

Other articles of this Issue 10/2014

Annals of Hematology 10/2014 Go to the issue

Original Article

High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)

Original Article

Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre

Original Article

A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma

Original Article

ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma

Original Article

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment

Original Article

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits